Member Info for Retireby40

Christ. GB banks on about last year being £17k EBITDA loss and a Quarter being profitable but it was ultimately a £3m loss with a £9m turnover. With, spend significantly up, margins falling and guidance 25% down does anyone really think (after EBITDA) there will be a profit?

The revenue silence s concern. Same as the last few updates. Odd they are not being transparent on what was the core competence and revenue generator.

Revenues for show profit for dough. Margins have reduced and no doubt admin expenses through the roof. Last year nearly EBITDA positive but exceptional items posted a near £3m loss. If we were likely to be profitable this year GB would have said so.

Again vague re labskin, doesn’t look good and I bet they’re burning cash. Thank feck for MWG.

Can someone ask GB on Twitter why the secrecy on what labskin is producing? It’s clearly deliberate as happened again.

All this talk of £100m IPO quite frankly ludicrous as it’s so premature. MWG is driving the growth here and given labskin will be producing a fair bit of revenue skintrustclub still very little contribution which is understandable given it’s embryonic but it illustrates why so many happy clappers here came down in the last shower and to be fair that wasn’t too recent ;)

The fact this was released on a Friday early August shows they are nervous about it.
Not a good look.

I don’t think it’s too bad but we have no news on cash position, how much has been drawn down etc so I guess we will get that in the interim next month.

Like the honesty re guidance and hopefully it is indeed conservative. What I don’t like is the vagueness (again) surrounding labskin revenues. That was the core business and now seems to be sidelined. This has been a consistent theme for a while and needs to be addressed.

I suspect this will still be a loss making yearn once exceptional items come into play. We have often been near to EBITDA positive and then bam we are a few million down once exceptional items come into play.

Hopefully positive news on skintrustclub to provide some cheap finance for growth.

I didn’t look back so apologies, yep 60k+ tests a month and we are nowhere near that yet need to look at options to fulfil increasing demand. It’s more smoke and mirrors IMO.

The market agrees, look at the share price. All there is to say.

After even these impressive contract RNSs the reason why we need still a 100% uplift to get to the last discounted raise price is because the market doesn’t trust GB insomuch as revenue for show and profit for dough. The market doesn’t believe we will turn a profit and remember in 2021 we had turnover a little over £9m and a loss of £3m. The point is servicing debt, really high admin expenses and paying for advertising new staff, all this lab space we can’t use (we have capacity for 90,0000 skintrustclub tests a month but can’t fulfil it) so costs a lot higher and will revenues (not sales) catch up? The market doesn’t believe so.

I hope that changes.

There was me thinking Modern water (with Rinocloud) monitored water and real time to establish if any undesirables are present. Microsaic came on board later so an a little miffed why our CEO is pushing Microsaic for monitoring and not MWG.

https://twitter.com/gjbrandon/status/1554488676117364740?s=21&t=4_fOsUzpAH4Iv6BayxfrAw

Rainwater everywhere on Earth contains cancer-causing ‘forever chemicals’, study finds. Who you gonna call? Monitor using @Microsaic detect #PFAS and #AMBC and desalination solutions are at your disposal @Modern_Water #DVRG to clean it

The Remuneration Committee needs to step up and make sure nothing beyond the (high for a loss making AIM PLC) salaries are awarded. Shambolic.

Hey Chesh, yep the KPIs welcomes but the seeming dishonesty from the CEO on labskin achieving significant growth is not. It was obvious (as I pointed out several times) given the MWG contract wins. Not sure why he has to ramp as he doesn’t do his credibility any good.

Clearly wirh skintrustclub labskin (testing products) will grow this year but GB stated I was wrong and it had grown from 20-21 which doesn’t seem to be the case.

Anyway, little point labouring it but just another example.

Good news today.

As I consistently speculated and stated.

He stayed what MWG contributed in 2021 which says labskin reduced from the prior year.

Chesh can you or someone please ask GB on Twitter why he said labskin grew last year when it didn’t (given what we know MWG contributed)? Interested to see his response as it’s not material (past info and results audited).

I always thought that was the case given the contracts we knew MWG had secured. It is somewhat surprising labskin revenue fell. I did point this out and was assured all divisions were growing. That clearly wasn’t the case.

Good to see the KPIs (rather than KIP’s as per the RNS!) and one expects they will continue reporting on each.

Looking forward to MWG ones being introduced. An encouraging presentation.

I asked a question about the range of fees products pay to test each one (if they are new) to feature
On the market place. Assuming the skintrustclub £1m revenue that was RNS’d labskin should have done very well out of the new products too.

Really hope shareholders don’t get short changed with any skintrustclub deal.

Anyway, let’s hope momentum builds as well as demand on both divisions.

Agree it’s too early to sell completely for fair value. Huge data bank as well as short term growth potential.

They could take investment for the labskin division under the group and give equity away in just that division.

Surely they could split the groups so they are owned subsidiaries on DVRG and if the right deal comes along they could sell X% to a VC or the like for £X To grow the business. Any future sale of divis gets divided appropriately.

Does labskin get a few for adding products to the marketplace as the below seems to suggest not -

Multiple streams of Skin Trust Club and Labskin revenues

As well as fee income from sales of skin care products recommended through Skin Trust Club App, the skin microbiome data continues to grow,